scholarly journals Can follow-up phone calls improve patients self-monitoring of blood glucose?

2016 ◽  
Vol 26 (1-2) ◽  
pp. 61-67 ◽  
Author(s):  
Cheryl Brown-Deacon ◽  
Terri Brown ◽  
Constance Creech ◽  
Marilyn McFarland ◽  
Anupama Nair ◽  
...  
2010 ◽  
Vol 30 (3) ◽  
pp. 329-335 ◽  
Author(s):  
Chiu-Yeh Tsai ◽  
Su-Chu Lee ◽  
Chi-Chih Hung ◽  
Jia-Jung Lee ◽  
Mei-Chuan Kuo ◽  
...  

♦ ObjectiveFalse elevation of blood glucose levels measured by glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ)-based glucose self-monitoring systems; glucometer) in peritoneal dialysis (PD) patients using icodextrin solution has been well documented. However, adverse hypoglycemic events caused by misreadings for blood glucose are still being reported. We aimed to study blood glucose levels measured simultaneously using different methods in PD patients with switching of icodextrin, and throughout daily exchanges either using icodextrin or not.♦ DesignWe recruited 100 PD patients, including 40 using icodextrin; 128 hemodialysis patients served as a reference. Fasting serum glucose was measured using our laboratory reference method (LAB) and 2 glucose self-monitoring systems based on glucose dehydrogenase nicotinamide adenine dinucleotide (GDH-NAD) and GDH-PQQ respectively. 80 PD patients had a second follow-up study. A time course study was performed in 16 PD patients through measuring fingertip glucose using the 2 glucose self-monitoring systems during daily exchanges.♦ ResultThe differences in measured serum glucose levels in (PQQ minus LAB) versus (NAD minus LAB) were markedly increased in PD patients using icodextrin compared to other patient groups, and was further confirmed by the follow-up study in patients that switched to icodextrin. The high serum glucose levels measured by the GDH-PQQ-based glucose self-monitoring system were present throughout all exchanges during the day in patients using icodextrin solution.♦ ConclusionsFalse elevation of blood glucose measured by GDH-PQQ-based glucose self-monitoring systems exists in patients using icodextrin. To avoid misinterpretation of hyperglycemia and subsequent over-injection of insulin, GDH-PQQ-based glucose self-monitoring systems should not be used in PD patients.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Lovise S. Heimro ◽  
Monica Hermann ◽  
Therese Thuen Davies ◽  
Anne Haugstvedt ◽  
Johannes Haltbakk ◽  
...  

Abstract Background Home care services plays an important role in diabetes management, and to enable older adults remain home-dwellers. Adequate follow-up and systematic nursing documentation are necessary elements in high quality diabetes care. Therefore, the purpose of this study was to examine the diabetes treatment and management for older persons with diabetes receiving home care services. Methods A cross-sectional study was used to assess the diabetes treatment and management in a Norwegian municipality. Demographic (age, sex, living situation) and clinical data (diabetes diagnose, type of glucose lowering treatment, diabetes-related comorbidities, functional status) were collected from electronic home care records. Also, information on diabetes management; i.e. follow-up routines on glycated haemoglobin (HbA1c), self-monitoring of blood glucose, insulin administration and risk factors (blood pressure, body mass index and nutritional status) were registered. HbA1c was measured upon inclusion. Descriptive and inferential statistics were applied in the data analysis. Results A total of 92 home care records from older home-dwelling persons with diabetes, aged 66–99 years were assessed. Only 52 (57 %) of the individuals had the diabetes diagnosis documented in the home care record. A routine for self-monitoring of blood glucose was documented for 27 (29 %) of the individuals. Only 2 (2 %) had individual target for HbA1c documented and only 3 (3 %) had a documented routine for measuring HbA1c as recommended in international guidelines. Among 30 insulin treated older individuals, a description of the insulin regimen lacked in 4 (13 %) of the home care records. Also, documentation on who performed self-monitoring of blood glucose was unclear or lacking for 5 (17 %) individuals. Conclusions The study demonstrates lack of documentation in home care records with respect to diagnosis, treatment goals and routines for monitoring of blood glucose, as well as insufficient documentation on responsibilities of diabetes management among older home-dwelling adults living with diabetes. This indicates that home care services may be suboptimal and a potential threat to patient safety.


2019 ◽  
Vol 23 (2) ◽  
pp. 21-26
Author(s):  
Elena V. Frolova ◽  
Alena I. Ogorelysheva ◽  
Ekaterina S. Spasenova ◽  
Tamara R. Khalilova

Chronic heart failure (CHF) is the most frequent and severe complication of cardiovascular disease (CVD). One of the most important aspects of management of patients with CHF remains to ensure adherence to treatment. The purpose of the study was to assess the effectiveness of therapy of patients with CHF with the use of a diary of self-control as a way of enhancing adherence to therapy. Materials and methods. A continuous sequential sample was used to select 40 patients with diagnosed Heart Failure II-IV FC (NYHA), who were then randomized into two groups: the follow-up group (n = 20) and the control group (n = 20). The study duration was 8 weeks. Patients of the observation group received materials on self-control (“Diary of a patient with heart failure”). For them, 3 control visits and 8 phone calls were organized once a week. The participants of the control group were observed in the usual conditions of practical health care; 3 control visits to the doctor were provided for them. The results obtained at week 8 of the study showed that the number of complaints of foot and Shin edema decreased by 2 times compared to the initial data; in the control group, the frequency of complaints did not have a positive dynamic. Conclusion. Use of a diary of self-control is the easiest method of improving adherence of patients with CHF to treatment.


2018 ◽  
Vol 8 (2) ◽  
Author(s):  
Victoria Eke

Hall, Wendy J. Diana’s Diabetes. CreateSpace Independent Publishing Platform, 2018. As part of the Mediwonderland book series designed to “guide children through common medical procedures and illnesses”, Diana’s Diabetes follows the journey of Diana, a young girl recently diagnosed with Type 1 diabetes, as she learns about her condition and how it is managed. Following the identification of symptoms and her initial diagnosis, Diana and her mother return to the clinic for an information session and follow-up with Dr. Daniel and Nurse Nina. There, Diana and her mother learn about the mechanics of the illness, self-monitoring for blood glucose, and insulin injections. Diana is also given a journal in which she must record her food intake and insulin doses, as well as a medical identification bracelet. Major concepts are introduced through text and accompanying illustrations. The text, printed in large font, is easy to read. The content is rolled out logically, allowing for one concept to build upon the previous. Colourful illustrations by Ysha Morco serve to complement the text, providing visuals for the various concepts presented. However, in the case of the “Type 1 Diabetes” poster illustrated on pages 15 and 16, more detail and additional labels could have been added to better explain the biology behind the illness. In addition to providing an informative and factually sound overview of Type 1 diabetes in children, author Wendy J. Hall has successfully created characters and a scenario that will undoubtedly resonate with patients and family members alike, serving as both a source of information and comfort. This book is highly recommended for public, elementary school, and children’s hospital libraries.  Highly Recommended: 4 out of 4 starsReviewer: Victoria Eke


Iproceedings ◽  
10.2196/15258 ◽  
2019 ◽  
Vol 5 (1) ◽  
pp. e15258
Author(s):  
Ronald Dixon ◽  
Howard Zisser ◽  
Nathan Barleen ◽  
Jennifer Layne ◽  
Daniel Moloney ◽  
...  

Background Telemedicine for people with type 2 diabetes (T2D) has the potential to positively impact self-management behaviors and improve health outcomes. The Onduo Virtual Diabetes Clinic (VDC) is a comprehensive telehealth program for people with T2D that combines mobile app technology, remote personalized lifestyle coaching from certified diabetes educators and health coaches, connected devices including blood glucose meters and continuous glucose monitoring systems, and clinical support from board certified endocrinologists. Objective To describe the VDC care delivery model and present preliminary data on change in glycemic control in program participants with up to 6 months of follow-up. Methods Adults ≥18 years of age with T2D and who were members of sponsoring health plans and employers throughout the US were eligible to participate. Those who elected to enroll downloaded the VDC app to their smartphone, provided demographic and clinical information, completed an onboarding survey, and were mailed a self-management kit that included a connected blood glucose meter, test strips and a home glycosylated hemoglobin (HbA1c) testing kit. Participants interacted with their care team primarily through the VDC app, with occasional phone calls, and by synchronous video consultations with endocrinologists, as clinically appropriate. Change in glycemic control in participants who completed a baseline survey from February 2018 through December 31, 2018, with an initial HbA1c measurement within 30 days of enrollment and a follow-up measurement between 90 and 180 days after baseline was analyzed. Results Participants (n=740) were (mean ± SD): 53.8 ± 8.8 years of age, 62% female, BMI 35.6 ± 8.5, initial HbA1c 7.7% ± 1.8, 31.0% were on insulin and 25.9% were on sulfonylureas at baseline, and 30.0% lived in a rural area. HbA1c decreased significantly by 2.3% ± 1.9, 0.7% ± 1.0 and 0.2% ± 0.8 across the baseline categories of >9.0%, 8.0% to 9.0% and 7.0% to <8.0%, respectively (all P<.001). Within these categories, HbA1c improved in 91.9%, 77.3% and 63.5% of participants. For the group with an initial HbA1c >9.0%, HbA1c decreased from 10.7% ± 1.4 to 8.3% ± 1.5, and when stratified by HbA1c ≥8.0% the mean decrease in HbA1c was 1.5%, from 9.5% ± 1.5 to 8.0% ± 1.3, with 84.5% of participants demonstrating improvement. Participants with an initial HbA1c <7.0% who were meeting treatment targets at baseline, HbA1c 6.3% ± 0.4, continued to maintain this level of glycemic control at follow-up, HbA1c 6.4% ± 0.6 (ns). Conclusions Participation in the VDC was associated with a significant improvement in HbA1c in adults with T2D who were not meeting treatment targets, with the greatest improvement observed in those with an initial HbA1c >9.0%. Importantly, the majority of program participants experienced an improvement in glycemic control. Our findings suggest that the VDC program is an effective approach to support individuals with T2D and their clinicians in diabetes management between office visits.


Sign in / Sign up

Export Citation Format

Share Document